Patients with respiratory allergies and allergic asthma, which are characterized by chronic type 2 airway inflammation, are often less susceptible to severe COVID-19. Lower viral replication is ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19), and it primarily infects cells in the respiratory tract. The human airway ...
The establishment of nasal mucosal immunity against SARS-CoV-2 through a nasal vaccine could be the most efficient way to combat COVID-19 infection. Understanding how viral infection occurs can ...
Researchers have found that nasal ciliated cells are targeted at the onset of COVID-19 infection, which may open the potential to prevent infection by establishing nasal mucosal immunity. The COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback